HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
Both vaccine candidates demonstrated a favorable safety and tolerability profile similar to the Pfizer-BioNTech COVID-19 Vaccine
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
Bringing next-gen cannabinoid therapeutics to cancer patients
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Both manufacturing facilities are based out of Benguluru, India
The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
The new program includes upstream and downstream process development and large-scale GMP production.
Subscribe To Our Newsletter & Stay Updated
